Storgate LLC Buys Shares of 1,634 HCA Healthcare, Inc. $HCA

Storgate LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,634 shares of the company’s stock, valued at approximately $763,000. HCA Healthcare accounts for 0.6% of Storgate LLC’s portfolio, making the stock its 24th largest position.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Martingale Asset Management L P acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $285,000. Milford Funds Ltd. acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $52,590,000. Korea Investment CORP raised its holdings in shares of HCA Healthcare by 10.1% during the fourth quarter. Korea Investment CORP now owns 156,185 shares of the company’s stock worth $72,917,000 after acquiring an additional 14,322 shares during the period. Y Intercept Hong Kong Ltd grew its position in HCA Healthcare by 403.1% in the fourth quarter. Y Intercept Hong Kong Ltd now owns 8,190 shares of the company’s stock valued at $3,824,000 after purchasing an additional 6,562 shares in the last quarter. Finally, L1 Capital International Pty Ltd grew its position in HCA Healthcare by 180.5% in the fourth quarter. L1 Capital International Pty Ltd now owns 91,987 shares of the company’s stock valued at $42,945,000 after purchasing an additional 59,188 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE HCA opened at $387.25 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The firm has a 50-day moving average of $429.60 and a 200-day moving average of $473.48. The stock has a market cap of $85.91 billion, a PE ratio of 13.32, a P/E/G ratio of 1.20 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter last year, the firm earned $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on HCA shares. Leerink Partners decreased their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Wells Fargo & Company decreased their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research report on Monday, April 27th. KeyCorp decreased their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. Finally, Argus cut their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $506.14.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.